320 related articles for article (PubMed ID: 14551261)
1. Repression of p65 transcriptional activation by the glucocorticoid receptor in the absence of receptor-coactivator interactions.
Wu J; Li Y; Dietz J; Lala DS
Mol Endocrinol; 2004 Jan; 18(1):53-62. PubMed ID: 14551261
[TBL] [Abstract][Full Text] [Related]
2. CBP (CREB binding protein) integrates NF-kappaB (nuclear factor-kappaB) and glucocorticoid receptor physical interactions and antagonism.
McKay LI; Cidlowski JA
Mol Endocrinol; 2000 Aug; 14(8):1222-34. PubMed ID: 10935546
[TBL] [Abstract][Full Text] [Related]
3. Role of steroid receptor coactivators in glucocorticoid and transforming growth factor beta regulation of plasminogen activator inhibitor gene expression.
Li G; Heaton JH; Gelehrter TD
Mol Endocrinol; 2006 May; 20(5):1025-34. PubMed ID: 16423881
[TBL] [Abstract][Full Text] [Related]
4. How glucocorticoid receptors modulate the activity of other transcription factors: a scope beyond tethering.
Ratman D; Vanden Berghe W; Dejager L; Libert C; Tavernier J; Beck IM; De Bosscher K
Mol Cell Endocrinol; 2013 Nov; 380(1-2):41-54. PubMed ID: 23267834
[TBL] [Abstract][Full Text] [Related]
5. Ligand-selective transactivation and transrepression via the glucocorticoid receptor: role of cofactor interaction.
Ronacher K; Hadley K; Avenant C; Stubsrud E; Simons SS; Louw A; Hapgood JP
Mol Cell Endocrinol; 2009 Feb; 299(2):219-31. PubMed ID: 19007848
[TBL] [Abstract][Full Text] [Related]
6. Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids.
Caldenhoven E; Liden J; Wissink S; Van de Stolpe A; Raaijmakers J; Koenderman L; Okret S; Gustafsson JA; Van der Saag PT
Mol Endocrinol; 1995 Apr; 9(4):401-12. PubMed ID: 7659084
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of heat shock transcription factor by GR.
Wadekar SA; Li D; Periyasamy S; Sánchez ER
Mol Endocrinol; 2001 Aug; 15(8):1396-410. PubMed ID: 11463862
[TBL] [Abstract][Full Text] [Related]
8. A novel, C-terminal dominant negative mutation of the GR causes familial glucocorticoid resistance through abnormal interactions with p160 steroid receptor coactivators.
Vottero A; Kino T; Combe H; Lecomte P; Chrousos GP
J Clin Endocrinol Metab; 2002 Jun; 87(6):2658-67. PubMed ID: 12050230
[TBL] [Abstract][Full Text] [Related]
9. Repression of the human glycoprotein hormone alpha-subunit gene by glucocorticoids: evidence for receptor interactions with limiting transcriptional activators.
Chatterjee VK; Madison LD; Mayo S; Jameson JL
Mol Endocrinol; 1991 Jan; 5(1):100-10. PubMed ID: 1708098
[TBL] [Abstract][Full Text] [Related]
10. Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors.
Scheinman RI; Gualberto A; Jewell CM; Cidlowski JA; Baldwin AS
Mol Cell Biol; 1995 Feb; 15(2):943-53. PubMed ID: 7823959
[TBL] [Abstract][Full Text] [Related]
11. Dissociation of steroid receptor coactivator 1 and nuclear receptor corepressor recruitment to the human glucocorticoid receptor by modification of the ligand-receptor interface: the role of tyrosine 735.
Stevens A; Garside H; Berry A; Waters C; White A; Ray D
Mol Endocrinol; 2003 May; 17(5):845-59. PubMed ID: 12569182
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-2 inhibits glucocorticoid receptor transcriptional activity through a mechanism involving STAT5 (signal transducer and activator of transcription 5) but not AP-1.
Biola A; Lefebvre P; Perrin-Wolff M; Sturm M; Bertoglio J; Pallardy M
Mol Endocrinol; 2001 Jul; 15(7):1062-76. PubMed ID: 11435608
[TBL] [Abstract][Full Text] [Related]
13. A new function for the C-terminal zinc finger of the glucocorticoid receptor. Repression of RelA transactivation.
Liden J; Delaunay F; Rafter I; Gustafsson J; Okret S
J Biol Chem; 1997 Aug; 272(34):21467-72. PubMed ID: 9261164
[TBL] [Abstract][Full Text] [Related]
14. Glucocorticoid receptor ligand binding domain is sufficient for the modulation of glucocorticoid induction properties by homologous receptors, coactivator transcription intermediary factor 2, and Ubc9.
Cho S; Kagan BL; Blackford JA; Szapary D; Simons SS
Mol Endocrinol; 2005 Feb; 19(2):290-311. PubMed ID: 15539428
[TBL] [Abstract][Full Text] [Related]
15. Role of activation function domain-1, DNA binding, and coactivator GRIP1 in the expression of partial agonist activity of glucocorticoid receptor-antagonist complexes.
Cho S; Blackford JA; Simons SS
Biochemistry; 2005 Mar; 44(9):3547-61. PubMed ID: 15736964
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the functional role of steroid receptor coactivator-1 in ligand-induced transactivation by thyroid hormone receptor.
Jeyakumar M; Tanen MR; Bagchi MK
Mol Endocrinol; 1997 Jun; 11(6):755-67. PubMed ID: 9171239
[TBL] [Abstract][Full Text] [Related]
17. Equilibrium interactions of corepressors and coactivators with agonist and antagonist complexes of glucocorticoid receptors.
Wang Q; Blackford JA; Song LN; Huang Y; Cho S; Simons SS
Mol Endocrinol; 2004 Jun; 18(6):1376-95. PubMed ID: 15016838
[TBL] [Abstract][Full Text] [Related]
18. α Actinin 4 (ACTN4) Regulates Glucocorticoid Receptor-mediated Transactivation and Transrepression in Podocytes.
Zhao X; Khurana S; Charkraborty S; Tian Y; Sedor JR; Bruggman LA; Kao HY
J Biol Chem; 2017 Feb; 292(5):1637-1647. PubMed ID: 27998979
[TBL] [Abstract][Full Text] [Related]
19. Glucocorticoid repression of AP-1 is not mediated by competition for nuclear coactivators.
De Bosscher K; Vanden Berghe W; Haegeman G
Mol Endocrinol; 2001 Feb; 15(2):219-27. PubMed ID: 11158329
[TBL] [Abstract][Full Text] [Related]
20. Alternate surfaces of transcriptional coregulator GRIP1 function in different glucocorticoid receptor activation and repression contexts.
Rogatsky I; Luecke HF; Leitman DC; Yamamoto KR
Proc Natl Acad Sci U S A; 2002 Dec; 99(26):16701-6. PubMed ID: 12481024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
